Modern TCM

The introduction of Compound Danshen Dripping Pills into major international markets encouraged us to promote the development of innovative TCM through globalization. We created a world-leading quality standard for the whole industry chain and upgraded to ecologically intelligent manufacturing processes. 

We continue R&D of innovative TCMs and also focus on secondary development of large varieties of drugs and the whole life cycle involving drug management. Our current R&D in the cardiovascular field covers hyperglycemia, blood clots, stroke, stroke sequela, heart failure, coronary heart disease etc., which has enabled us to provide a complete product chain suited for prevention, treatment, and rehabilitation of cardiovascular diseases. We have thus leveraged the benefits of innovative TCMs in the cardiovascular and cerebrovascular field.